Evolution of the Average Target: Arecor Therapeutics plc

Evolution of the Average Target - Arecor Therapeutics plc

Evolution of the Target Price: Arecor Therapeutics plc

Evolution of the Target Price - Arecor Therapeutics plc

Changes in Analyst Recommendations: Arecor Therapeutics plc

ab75e5a.5hvG9uB5csBRVCtcBZmgB58l0VqAU_q6lxyuldD1MHc.q2-pgbcdBo0-GWcpR-70Q-oU4jH6IcL9-1qd74_ARzyRa5XHrzMEtjl5Zg~774a9424f0a13b3615cd00169759d7ab

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +203.64%
+42.48%
+24.46%
+8.41%
+15.87%
+17.86%
+35.3%
+1.94%
+41.27%
+72.28%
Average +46.35%
Weighted average by Cap. +27.04%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8250GBP
Average target price
2.505GBP
Spread / Average Target
+203.64%
High Price Target
2.510GBP
Spread / Highest target
+204.24%
Low Price Target
2.500GBP
Spread / Lowest Target
+203.03%

Analyst Consensus Detail

Analyst consensus - Arecor Therapeutics plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Arecor Therapeutics plc
  1. Stock Market
  2. Stocks
  3. AREC Stock
  4. Consensus Arecor Therapeutics plc